Director Buys $100K in Lantern Pharma Offering

summarizeSummary

A director of Lantern Pharma Inc. purchased over $100,000 worth of common stock in the company's recent offering, signaling insider confidence.

check_boxKey Events

• Director Participates in Offering

  Director D. Jeffrey Keyser acquired 48,544 shares of common stock for $100,000.64 at a price of $2.06 per share on May 12, 2026.

• Insider Confidence Signal

  This open market purchase, representing 0.283% of the company's market cap, indicates a vote of confidence from a director following the recent capital raise.

• Linked to Recent Offering

  The shares were acquired as part of the company's offering that closed on May 14, 2026, which was announced on May 13 and finalized on May 14.

auto_awesomeAnalysis

Director D. Jeffrey Keyser's $100,001 purchase of common stock in Lantern Pharma's recent offering demonstrates insider confidence following the capital raise. This investment, made at the offering price, aligns the director's interests with shareholders after the company secured new funding, which is particularly notable given the company's prior 'going concern' warning.